Bruce Weissman Email & Phone Number

South San Francisco, California, US

Franklin Lakes, New Jersey, US

Launched InVisionFirst Lung liquid biopsy testing by Next Generation Sequencing for advanced Non-Small Cell Lung Cancer patients

Austin, Texas, US

Genetics and Oncology testing kit sales to highly complex molecular laboratories in a 10 state territory. Technologies include PCR, qPCR, Capillary Electrophoresis and Next Generation Sequencing

Waltham, MA, US

Allergy and autoimmune equipment and reagent sales for the Immunodiagnostics Division (formerly Phadia) in the Southeast, US.

San Diego, CA, US

• Initially hired as Molecular Sales Specialist; subsequent roles included Molecular Sales Director and Health Systems Director - Molecular, prior to promotion to last role.
• Identified and secured Key Opinion Leader and large molecular laboratory relationships to gauge market relevance of existing and future products while looking for new partnership opportunities.
• Explored opportunities to collaborate with customers on studies and developmental projects.
• Responsible for sales of molecular products into targeted Integrated Health Networks, Reference Labs, GPOs and Government accounts.

Bedford, MA, US

• Transferred from The Binding Site in a similar leadership role when the autoimmune portion of The Binding Site was acquired by Inova. Managed 7 Technical Sales Specialists.
• Created new pricing tools and sales reports to greatly reduce errors, standardize, and reduce time spent on non-selling activities.
• Member of management team that created a formal training program for new sales representatives including writing the Inflammatory Bowel Disease module.

Birmingham, West Midlands, GB

Managed 6 Technical Sales Representatives selling autoimmune and serum protein assays and capital equipment prior to Inova acquisition. Created new pricing tools and standardized proposals to reduce time spent on these tasks by over 75%.

Switzerland 🇨🇭, CH

• Consistent track record of achievement and territory growth in an expansion territory for this market leader in nucleic acid based diagnostic and prognostic testing. Clientele included recognized leaders and innovators.
• Premier Performers Club 2002 and 2003.
• Achieved 24% growth of territory in 2000, 49% growth in 2001 and 19.5% growth in 2002.
• Far exceeded instrument goals with 196% in 2002, 151% in 2003 and 195% in 2004.

Recruited by former manager at Cambridge Biotech. Managed the five state, Gulf States sales territory for this manufacturer of diagnostic virology products and equipment. Obtained business through demonstration of products with the aid of workflow and cost savings financial analyses. Planned and conducted demonstration road shows for new automated ELISA.